Key result
The provided abstract contains only author affiliations and conflict of interest disclosures regarding patents for stroke volume variation.
Key points are not available for this paper at this time.
Patent disclosures alone yield no outcome data; leaves open any role for stroke volume variation monitoring.
Edwards Lifesciences, Nyon, Vaud, Switzerland Dr. Michard is a director at Edwards Lifesciences; he is also co-inventor on patent US 2007179386 (method to detect automatically and correct for limitations to the use of stroke volume variation, pulse pressure variation, or pulse oximetry variation) and on patent US 2010137828 (closed loop systems integrating stroke volume variation, pulse pressure variation, or pulse oximetry variation as input parameters).
No takes yet. Share an insight, caveat, or question.
Frédèric Michard (2011) studied this question. The provided abstract contains only author affiliations and conflict of interest disclosures regarding patents for stroke volume variation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: